New antiepileptic drugs in epileptology

Neuropsychobiology

Volumn 38, Issue 3, 1998, Pages 145-148

  Elger, Christian E ^a,b   Bauer, Jürgen ^a  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

Antiepileptic drugs; Epilepsy; Treatment of epilepsies

Indexed keywords

4 AMINOBUTYRIC ACID; ANTICONVULSIVE AGENT; CARBAMAZEPINE; FELBAMATE; GABAPENTIN; LAMOTRIGINE; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; TIAGABINE; TOPIRAMATE; VALPROIC ACID; VIGABATRIN;

AGGRESSION; CLINICAL TRIAL; CONFERENCE PAPER; DEPRESSION; EPILEPSY; HUMAN; HYPONATREMIA; LENNOX GASTAUT SYNDROME; LIVER TOXICITY; META ANALYSIS; PRIORITY JOURNAL; PSYCHOSIS; RASH; SEIZURE; WEIGHT REDUCTION;

ANTICONVULSANTS; DRUG THERAPY, COMBINATION; EPILEPSY; HUMANS; TREATMENT OUTCOME;

EID: 0031725190     PISSN: 0302282X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000026530     Document Type: Conference Paper

References (23)

1. Britton JW, So EL: New antiepileptic drugs: Prospects for the future. J Epilepsy 1995;8:267 281.
2. Dichter MA: Basic mechanisms of epilepsy: Targets for therapeutic intervention. Epilepsia 1997;38(suppl 9):S2-S6.
3. Meldrum BS: Identification and preclinical testing of novel antiepileptic compounds. Epilepsia 1997;38(supp 9):S7-S15.
4. Grant SM, Heel RC: Vigabatrin. Drugs 1991; 41:889-926.
5. Eadie MJ: Anticonvulsant drugs. An update. Drugs 1984;27:328-363.
6. Cocito L, Maffioni M, Loeb C: Long-term observations on the clinical use of lamotrigine as add-on drug in patients with epilepsy. Epilepsy Res 1994;19:123-127.
7. Schapel GJ, Black AB, Lam EL, Robinson M. Dollman WB: Combination vigabatrin and lamotrigine therapy for intractable epilepsy. Seizure 1996;5:51-56.
8. Bauer J, Elger CE: Medikamentöse antikonvulsive Therapie. Nervenarzt 1995;66:403-411.
9. Bauer J, Helmstaedter C, Elger CE: Nonconvulsive status epilepticus with generalized 'fast activity'. Seizure 1997;6:67-70.
10. Pellock JM, Brodie MJ: Felbamate: 1997 update. Epilepsia 1997;38:1261 1264.
11. Uthman BM, Rowan AJ, Ahmann PA, Leppik IE, Schachter SC, Sommerville KW, Shu V: Tiagabine for complex partial seizures. Arch Neurol 1998;55:56-62.
12. Bauer J, Stawowy B, Lenders T, Bettig U, Elger CE: Efficacy and tolerability of tiagabine: Results of an add-on study in patients with refractory partial seizures. J Epilepsy 1995;8:83-86.
13. Perucca E, Bialer M: The clinical pharmacokinetics of the newer antiepileptic drugs. Clin Pharmacokinet 1996;31:29-46.
14. Perucca E: Pharmacologic advantages of antiepileptic drug monotherapy. Epilepsia 1997; 38(suppl 5):S6-S8.
15. Gram L: Antiepileptic drug monotherapy designs in clinical trials. Epilepsia 1997;38(suppl 5): S14 S16.
16. Genton P, Roger J: Antiepileptic drug monotherapy versus polytherapy: A historical perspective. Epilepsia 1997;38(suppl 5):S2-S5.
17. Beydoun A: Monotherapy trials of new antiepileptic drugs. Epilepsia 1997;38(suppl 9):S21 S31.
18. Shorvon S: Antiepileptic drugs monotherapy versus polytherapy: Economic aspects. Epilepsia 1997;38(suppl 5):S17 S20.
19. Mattson RH: Antiepileptic drug monitoring: A reappraisal. Epilepsia 1995;36(suppl 5):S22 S29.
20. Schachter SC: Advances in the assessment of refractory epilepsy. Epilepsia 1993;34(suppl 5): S24-S30.
21. Santavuori P: Absence seizures: Valproate or ethosuximide? Acta Neurol Scand 1983; 68(suppl 97):41-93.
22. Bauer J, Elger CE: Chronic idiopathic absence epilepsy: Efficacy of antiepileptic drug treatment. SYCP Epilepsy 1998;5:10-11.
23. Jallon P: The problem of intractability: The continuing need for new medical therapies in epilepsy. Epilepsia 1997;38(suppl 9):S37-S42.